2024 Q4 Form 10-Q Financial Statement

#000110465924117760 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $30.89K
YoY Change 29.52%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$16.53M
YoY Change 71.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $12.97M
YoY Change 85.66%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$3.565M
YoY Change 35.55%
Net Earnings / Revenue
Basic Earnings Per Share $0.05
Diluted Earnings Per Share $0.05
COMMON SHARES
Basic Shares Outstanding 66.73M 64.60M
Diluted Shares Outstanding 65.54M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $11.21M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $924.6K
Receivables $8.822M
Other Receivables
Total Short-Term Assets $20.96M
YoY Change 100.81%
LONG-TERM ASSETS
Property, Plant & Equipment $474.0K
YoY Change 21.78%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $68.34M
YoY Change -10.37%
TOTAL ASSETS
Total Short-Term Assets $20.96M
Total Long-Term Assets $68.34M
Total Assets $89.29M
YoY Change 3.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.090M
YoY Change 8.36%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.090M
Total Long-Term Liabilities
Total Liabilities $12.09M
YoY Change -9.41%
SHAREHOLDERS EQUITY
Retained Earnings -$590.9M
YoY Change 2.44%
Common Stock $632.7M
YoY Change 2.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $77.21M
YoY Change
Total Liabilities & Shareholders Equity $89.29M
YoY Change 3.02%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$3.565M
YoY Change 35.55%
Depreciation, Depletion And Amortization $30.89K
YoY Change 29.52%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001526243
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2023Q4 us-gaap Government Assistance Current Statement Of Financial Position Extensible Enumeration
GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccountsReceivableNetCurrent
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Government Assistance Current Statement Of Financial Position Extensible Enumeration
GovernmentAssistanceCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccountsReceivableNetCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39918
dei Entity Registrant Name
EntityRegistrantName
Perpetua Resources Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Address Address Line1
EntityAddressAddressLine1
405 S. 8th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 201
dei Entity Address City Or Town
EntityAddressCityOrTown
Boise
dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83702
dei City Area Code
CityAreaCode
208
dei Local Phone Number
LocalPhoneNumber
901-3060
dei Security12b Title
Security12bTitle
Common Shares, without par value
dei Trading Symbol
TradingSymbol
PPTA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66726710
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11210662
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3229462
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8822428
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3181152
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
924601
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
443312
CY2024Q3 us-gaap Assets Current
AssetsCurrent
20957691
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6853926
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
474013
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
385049
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44707
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27898
CY2024Q3 ppta Mine Reclamation Asset Bond
MineReclamationAssetBond
3000000
CY2023Q4 ppta Mine Reclamation Asset Bond
MineReclamationAssetBond
3000000
CY2024Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
64818480
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
72820365
CY2024Q3 us-gaap Assets
Assets
89294891
CY2023Q4 us-gaap Assets
Assets
83087238
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
7295805
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4997226
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
44706
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
27897
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
1500000
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
2000000
CY2024Q3 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
249357
CY2023Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
764607
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9089868
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7789730
CY2024Q3 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
3000000
CY2023Q4 us-gaap Litigation Reserve Noncurrent
LitigationReserveNoncurrent
3000000
CY2024Q3 us-gaap Liabilities
Liabilities
12089868
CY2023Q4 us-gaap Liabilities
Liabilities
10789730
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66569376
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64123456
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
632677284
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
618581910
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
35408923
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
34413562
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-590881184
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-580697964
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
77205023
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
72297508
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89294891
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
83087238
CY2024Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
572176
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
393656
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1618354
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1205824
CY2024Q3 us-gaap Depreciation
Depreciation
30886
CY2023Q3 us-gaap Depreciation
Depreciation
23846
us-gaap Depreciation
Depreciation
88639
us-gaap Depreciation
Depreciation
59548
CY2024Q3 us-gaap Officers Compensation
OfficersCompensation
54436
CY2023Q3 us-gaap Officers Compensation
OfficersCompensation
30158
us-gaap Officers Compensation
OfficersCompensation
371518
us-gaap Officers Compensation
OfficersCompensation
310268
CY2024Q3 us-gaap Exploration Expense
ExplorationExpense
14510853
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
8664205
us-gaap Exploration Expense
ExplorationExpense
31517250
us-gaap Exploration Expense
ExplorationExpense
20683257
CY2024Q3 us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
854662
CY2023Q3 us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
22285
us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
1422288
us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
604222
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
5000000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
140829
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
160264
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
403966
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
454543
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
253185
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
230243
us-gaap Professional Fees
ProfessionalFees
1046200
us-gaap Professional Fees
ProfessionalFees
875327
CY2024Q3 ppta Shareholder And Regulatory Expense
ShareholderAndRegulatoryExpense
117880
CY2023Q3 ppta Shareholder And Regulatory Expense
ShareholderAndRegulatoryExpense
91177
ppta Shareholder And Regulatory Expense
ShareholderAndRegulatoryExpense
381745
ppta Shareholder And Regulatory Expense
ShareholderAndRegulatoryExpense
388307
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16534907
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9615834
us-gaap Operating Income Loss
OperatingIncomeLoss
-36849960
us-gaap Operating Income Loss
OperatingIncomeLoss
-29581296
CY2024Q3 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
12920417
CY2023Q3 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
6905691
us-gaap Government Assistance Amount
GovernmentAssistanceAmount
26565798
us-gaap Government Assistance Amount
GovernmentAssistanceAmount
14273148
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
41810
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
92620
us-gaap Investment Income Interest
InvestmentIncomeInterest
101168
us-gaap Investment Income Interest
InvestmentIncomeInterest
418670
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7700
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12571
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-226
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13461
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12969927
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6985740
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26666740
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14678357
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3564980
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2630094
us-gaap Net Income Loss
NetIncomeLoss
-10183220
us-gaap Net Income Loss
NetIncomeLoss
-14902939
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65537015
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65537015
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63176063
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63176063
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64735961
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64735961
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63120580
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63120580
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
85830522
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
840827
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40672
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4600093
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
82111928
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
784282
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
41519
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7672752
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
75264977
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
696066
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2630094
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
73330949
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
72297508
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1008077
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2944525
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
70361060
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
950158
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
986027
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-3673715
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
68623530
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
947537
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11005174
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
606871
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
800633
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3564980
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
77205023
us-gaap Profit Loss
ProfitLoss
-10183220
us-gaap Profit Loss
ProfitLoss
-14902939
us-gaap Share Based Compensation
ShareBasedCompensation
2905772
us-gaap Share Based Compensation
ShareBasedCompensation
2321175
us-gaap Depreciation
Depreciation
88639
us-gaap Depreciation
Depreciation
59548
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1732
us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
1422288
us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
604222
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-3193
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
160
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
13333
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
25000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5641276
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1698358
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
281721
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
738397
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2298579
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2792882
ppta Increase Or Decrease In Settlement Payable
IncreaseOrDecreaseInSettlementPayable
-500000
ppta Increase Or Decrease In Settlement Payable
IncreaseOrDecreaseInSettlementPayable
5000000
us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
1937538
us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
8650891
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11838617
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15239650
ppta Payments For Deposits On Purchase Of Property Plant And Equipment
PaymentsForDepositsOnPurchaseOfPropertyPlantAndEquipment
199568
ppta Proceeds From Sale Of Royalty Interests In Mining Properties Net
ProceedsFromSaleOfRoyaltyInterestsInMiningPropertiesNet
8335115
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
333230
us-gaap Payments To Acquire Mineral Rights
PaymentsToAcquireMineralRights
275992
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176270
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153820
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
12000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
25000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7638047
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-404812
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11005174
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
606871
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1786660
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82191
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12184963
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
82191
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-3193
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
161
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7981200
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15562110
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3229462
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22667047
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11210662
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7104937
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
65972
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
65061
CY2024Q3 us-gaap Cash
Cash
6066328
CY2023Q3 us-gaap Cash
Cash
3104628
CY2024Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
5144334
CY2023Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
4000309
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11210662
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7104937
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">1.</b></span>Nature of Operations and Basis of Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">Perpetua Resources Corp. (the “Corporation”, the “Company”, “Perpetua Resources” or “Perpetua”) was incorporated on February 22, 2011 under the <i style="font-style:italic;">Business Corporation Act</i> (British Columbia). The Company was organized to hold shares in wholly owned subsidiaries that locate, acquire, develop and restore mineral properties located principally in the Stibnite – Yellow Pine mining district in Valley County, Idaho, USA. The Company’s principal asset is 100% ownership in subsidiaries that control the Stibnite Gold Project (“Stibnite Gold Project” or the “Project”). The Company currently operates in one segment, mineral exploration in the United States.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of Perpetua Resources Corp. and its wholly owned subsidiaries, Perpetua Resources Idaho, Inc. and Idaho Gold Resource Company, LLC. Intercompany transactions and balances have been eliminated. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The unaudited condensed consolidated financial statements do not include all disclosures required of annual consolidated financial statements and, accordingly, should be read in conjunction with our annual financial statements for the year ended December 31, 2023. Operating results for the nine months ended September 30, 2024 may not be indicative of results expected for the full year ending December 31, 2024. Management estimates that the Company’s 2024 effective tax rate will be 0% due to the Company’s cumulative loss position, historical net operating losses (“NOLs”), and other available evidence related to the Company’s ability to generate taxable income. Accordingly, there is no income tax provision or benefit for the nine month period ended September 30, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the results for the interim periods reported.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">The Company’s latest liquidity forecast indicates that available cash resources and other sources of liquidity are expected to be exhausted in the second quarter of 2025. Although the Company’s current capital resources and liquidity include up to $20.0 million in funding awarded under the modified Technology Investment Agreement (“TIA”) pursuant to Title III of the Defense Production Act (“DPA”) as of September 30, 2024, such funding is available only for the specified costs related to permitting, environmental baseline data monitoring, environmental and technical studies, and advancing construction readiness and is not available to fund certain corporate expenses, including under the Settlement Agreement (as defined below). Absent additional financing, the Company would no longer be able to meet its ongoing obligations or progress critical permitting efforts. The Company continues to explore various strategic and funding opportunities, which may include the issuance of additional equity, new debt, or project specific debt; government funding; and/or other financing or strategic opportunities. The Company has engaged RBC Capital Markets and Endeavour Financial to assist with the evaluation of potential strategic and financing opportunities and to support the Company’s application process in connection with the U.S. EXIM $1.8 billion Letter of Interest received in April 2024. Any such financing or strategic transaction, or any funding commitment from U.S. EXIM, will be subject to due diligence and other conditions. There can be no assurance of the amount, timing or nature of any such financing or strategic transaction, if any.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">On May 12, 2023, the Company entered into a Controlled Equity Offering<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">SM</sup> Sales Agreement (the “Sales Agreement”) providing for the sale by the Company, from time to time, of its common shares having an aggregate gross offering price of up to $20.0 million. Sales under the program are subject to certain conditions, including market conditions, and there is no assurance that the Company will be able to raise funds under the program, at acceptable share prices or at all. As of September 30, 2024, $6.2 million remains available under the program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">We believe our plans outlined above to obtain sufficient funding will be successful although there is no certainty that these plans will result in needed liquidity for a reasonable period of time. However, our expectation of incurring costs in the foreseeable future that are not eligible for DPA funding reimbursement and the need for additional funding to further support the development of our planned operations, raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these unaudited condensed consolidated financial statements are issued. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 36pt;">These unaudited condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business and do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 36pt;"><i style="font-style:italic;">Loss per share</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">Basic loss per share is computed by dividing the net loss by the weighted average number of shares outstanding during the reporting period. Diluted loss per share is computed similar to basic loss per share except that the weighted average shares outstanding are increased to include additional shares for the assumed exercise of share purchase options and vesting and distribution of awarded share units, if dilutive. The Company’s potential dilutive common shares include outstanding share purchase options, restricted share units, performance share units, and deferred share units. Potentially dilutive shares as of September 30, 2024 and 2023, are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:22.91%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September 30,</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share purchase options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 946,209</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,673,750</p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Share units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 2,260,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 1,375,820</p></td></tr><tr><td style="vertical-align:bottom;width:75.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Balance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,206,959</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 3,049,570</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 36pt;">All potentially dilutive shares were excluded from the calculation of diluted loss per share as their exercise and conversion would be anti-dilutive.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q2 ppta Potential Funding Commitment Export Import Bank
PotentialFundingCommitmentExportImportBank
1800000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3206959
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3049570
CY2024Q3 us-gaap Mineral Properties Net
MineralPropertiesNet
64818480
CY2023Q4 us-gaap Mineral Properties Net
MineralPropertiesNet
72820365
CY2024Q1 ppta Gross Proceeds From Royalty
GrossProceedsFromRoyalty
8500000
CY2024Q1 ppta Sale Of Mineral Royalty Interests Transaction Costs
SaleOfMineralRoyaltyInterestsTransactionCosts
164835
ppta Proceeds From Sale Of Royalty Interests In Mining Properties Net
ProceedsFromSaleOfRoyaltyInterestsInMiningPropertiesNet
8335115
ppta Annual Payments Due Under Option Agreements
AnnualPaymentsDueUnderOptionAgreements
180000
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
947537
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
696066
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2905772
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2321175
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0438
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0415
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5736
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6574
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
200000
us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
1900000
CY2024Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
200000
CY2023Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
764607
CY2022Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
10800936
ppta Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
true
ppta Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration Not Disclosed Flag
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumerationNotDisclosedFlag
true
us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
1422288
us-gaap Environmental Remediation Expense
EnvironmentalRemediationExpense
604222
us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
1937538
us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
8650891
CY2024Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
249357
CY2023Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
2754267
CY2024Q3 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
249357
CY2023Q3 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
2297523
CY2023Q3 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
456744
CY2024Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
249357
CY2023Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
2754267
CY2021Q4 us-gaap Security Deposit
SecurityDeposit
7500000
CY2021Q1 ppta Payment Of Cash Collateral
PaymentOfCashCollateral
3000000.0
CY2024Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
0
us-gaap Accrual For Environmental Loss Contingencies Payments1
AccrualForEnvironmentalLossContingenciesPayments1
1900000
CY2024Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
200000
CY2024Q3 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
12920417
CY2023Q3 us-gaap Government Assistance Amount
GovernmentAssistanceAmount
6905691
us-gaap Government Assistance Amount
GovernmentAssistanceAmount
26565798
us-gaap Government Assistance Amount
GovernmentAssistanceAmount
14273148
CY2024Q3 us-gaap Government Assistance Amount Cumulative Current
GovernmentAssistanceAmountCumulativeCurrent
8770244
CY2023Q4 us-gaap Government Assistance Amount Cumulative Current
GovernmentAssistanceAmountCumulativeCurrent
3127770
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001104659-24-117760-index-headers.html Edgar Link pending
0001104659-24-117760-index.html Edgar Link pending
0001104659-24-117760.txt Edgar Link pending
0001104659-24-117760-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ppta-20240930.xsd Edgar Link pending
ppta-20240930x10q.htm Edgar Link pending
ppta-20240930x10q004.jpg Edgar Link pending
ppta-20240930xex31d1.htm Edgar Link pending
ppta-20240930xex31d2.htm Edgar Link pending
ppta-20240930xex32d1.htm Edgar Link pending
ppta-20240930xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ppta-20240930_cal.xml Edgar Link unprocessable
ppta-20240930_def.xml Edgar Link unprocessable
ppta-20240930_lab.xml Edgar Link unprocessable
ppta-20240930_pre.xml Edgar Link unprocessable
ppta-20240930x10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending